IAM empfiehlt auch dieses Jahr sechs unserer Partner:innen, Dr. Eva Dörner, Dr. Eva Ehlich, Dr.-Ing. Sophie Ertl, Dr. Naho Fujimoto, Dr. Martin Huenges und Dr. Marco Stief als weltweit führende Strateg:innen für geistiges Eigentum.
Der IAM Strategy Guide listet jedes Jahr die Personen auf, die über herausragende Fähigkeiten bei der Entwicklung und Umsetzung von Strategien zur Maximierung des Wertes von Patenten, Urheberrechten, Marken und anderen IP-Rechten verfügen. Es werden dabei nur jene aufgeführt, die mehrfach von verschiedenen Parteien als hervorragende IP-Strateg:innen genannt wurden.
IAM-Herausgeber Joff Wild betont, dass IP-Strateg:innen wichtiger als je zuvor seien. Umso mehr freut es uns, dass die ausgezeichnete Arbeit unserer Kolleg:innen Anerkennung in der Nominierung findet.
IAM sagt:
- For strategic advice in the fields of chemistry and plant protection, organic chemistry PhD Eva Dörner is a discerning choice. She secures, maintains and builds up her clients’ key assets with finesse and great commercial astuteness.
- “An extremely safe pair of hands for complex IP issues and top-level portfolio strategy in the pharmaceutical and biotechnology space, Eva Ehlich is commercially and culturally astute and easily grapples with the complexities and politics of larger international projects.”
- “A highly qualified patent attorney, Sophie Ertl has a canny forward-thinking approach to developing her client’s patent strategy. She is detail-oriented, technically-savvy and communicates complex concepts in a manner that is easy to understand – she is an asset to any team.”
- “Through careful white space analyses and a deep understanding of the prior art landscape as well as a remarkable knowledge of the pharmaceutical industry, Naho Fujimoto anticipates possible hurdles and develops thoughtful strategies that maximise her client’s opportunities.”
- “A global thinker and favourite among in-house counsel, Martin Huenges is an excellent attorney who really knows his way around EPO and German patenting procedures and easily translates business realities into sophisticated IP proposals to give ultimate value to his clients.”
- Marco Stief is one of the leading individuals in Germany for patent strategy, particularly in the pharmaceutical field. Marco maintains one of the best Supplementary Protection Certificate practices in the country and is considered a thought leader in this space.
Zur 2022 IAM 300 Pressemitteilung (nur auf englisch verfügbar).
